Nitin Ohri
NRG Oncology · Albert Einstein College of Medicine · Montefiore Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Nitin Ohri as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:11 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07835789 · Testing Repeat Radiation Therapy for Recurrent Non-small Cell Lung CancerNRG Oncology · not yet recruiting · Locally Recurrent Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8 · principal investigator
- Ph2NCT06865339 · Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung CancerMontefiore Medical Center · recruiting · NSCLC, Locally Advanced · principal investigator
- N/ANCT06342284 · Patient-Generated Health Data Collection During Chemoradiotherapy for Lung CancerThe New York Proton Center · recruiting · Thoracic Cancer · principal investigator
- N/ANCT04878952 · Testing the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung CancerNRG Oncology · terminated · Non-small Cell Lung Cancer, Non-small Cell Lung Cancer Stage III, Recurrent Non Small Cell Lung Cancer · principal investigator
- Ph3NCT04592861 · Carbon Ion RT for Locally Advanced Pancreatic CancerAlbert Einstein College of Medicine · terminated · Pancreatic Cancer · principal investigator
- Ph2NCT03523702 · The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC TrialMontefiore Medical Center · completed · Non-small Cell Lung Cancer, NSCLC · principal investigator
- Ph2NCT03481114 · Patient-Reported Outcomes Following Chemoradiotherapy for Locally Advanced Non-small Cell Lung CancerAlbert Einstein College of Medicine · completed · Non-small Cell Lung Cancer · principal investigator
- N/ANCT03115398 · A Simple Walking Program to Enhance Concurrent Chemoradiotherapy DeliveryMontefiore Medical Center · completed · Brain Cancer, Head and Neck Cancer, Lung Cancer · principal investigator
- Ph2NCT02839265 · FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung CancerMontefiore Medical Center · completed · Non-small Cell Lung Cancer (NSCLC) · principal investigator
- N/ANCT02649569 · Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal CancerMontefiore Medical Center · completed · Digestive System Carcinoma, Head and Neck Carcinoma, Lung Carcinoma · principal investigator
- Ph2NCT02073968 · PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung CancerAlbert Einstein College of Medicine · completed · Metastatic Malignant Neoplasm in the Brain, Recurrent Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma · principal investigator
- N/ANCT01899261 · Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryMontefiore Medical Center · completed · Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Localized Non-Resectable Adult Liver Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Montefiore Academic Community NCORP ProgramUG1CA189859 · NCI · MONTEFIORE MEDICAL CENTER (BRONX, NY) · fiscal years 2023 to 2026 · $854,906 awarded in 2026Same name and institution; not confirmed by an ID
- Protocol Review and Monitoring SystemP30CA013330 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2023 to 2026 · $136,762 awarded in 2026Grant number is on one of their registry trials
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- NRG Oncology Network Group Operations CenterU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Quynh-Thu Xuan Le, ROBERT S. MANNEL, NORMAN WOLMARK · fiscal years 2014 to 2026Named on NCT07835789
Most cited trial papers
Clinical-trial papers with this author name in non-small cell lung cancer, ranked by citations from NIH iCite, fetched 2026-11-12 11:11 UTC. The ranking covers the 200 most relevant of 2 PubMed records, and a shared surname and initials can bring in a namesake. All 2 on PubMed
- Daily Step Counts: A New Prognostic Factor in Locally Advanced Non-Small Cell Lung Cancer?Int J Radiat Oncol Biol Phys · 201955 citationsRCR 2.3
- Randomized Evaluation of the PET-Adjusted IMRT for NSCLC Trial (REPAINT).Int J Radiat Oncol Biol Phys · 20258 citationsRCR 1.6